Explore the details of the Abbvie Inc. V. Qilu Pharma, Inc. case under case number 3:24-cv-06759 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
3:24-cv-06759
Filing Date
Jun 6, 2024
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
QILU ANTIBIOTICS PHARMACEUTICAL CO., LTD. -
FRESENIUS KABI USA, LLC -
ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED -
APOTEX INC. -
ABBVIE INC. -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

Docket entries not found - set an alert to get notified when docket entries are added.